Astaxanthin in Liver Health and Disease: A Potential Therapeutic Agent

被引:51
|
作者
Li, Jingjing [1 ]
Guo, Chuanyong [2 ]
Wu, Jianye [1 ]
机构
[1] Tongji Univ, Putuo Peoples Hosp, Dept Gastroenterol, Sch Med, Shanghai 200060, Peoples R China
[2] Tongji Univ, Shanghai Peoples Hosp 10, Dept Gastroenterol, Sch Med, Shanghai 200072, Peoples R China
来源
关键词
astaxanthin; liver diseases; antioxidants; inflammation; anticancer; HEPATIC STELLATE CELLS; DIET-INDUCED OBESITY; OXIDATIVE STRESS; PPAR-GAMMA; INHIBITS PROLIFERATION; SUBCHRONIC TOXICITY; CAROTENOIDS; APOPTOSIS; INJURY; MICE;
D O I
10.2147/DDDT.S230749
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Astaxanthin is a carotenoid derived from oxygen-containing non-vitamin A sources and is mainly obtained from marine organisms. Studies have demonstrated that astaxanthin is a natural antioxidant product and it is widely used in the fields of medicine, health-care products and cosmetics. Studies have shown that astaxanthin has important preventive and therapeutic effects on liver fibrosis, non-alcoholic fatty liver, liver cancer, drug and ischemia-induced liver injury, and its mechanism is related to antioxidant and anti-inflammatory activities, and the regulation of multiple signaling pathways. In this review, we discuss the latest data on astaxanthin in the prevention and treatment of liver diseases. An understanding of the structure, source and mechanism of action of astaxanthin in the body would not only provide a theoretical basis for its clinical application but could also have important significance in screening and improving related compounds for the treatment of liver diseases.
引用
收藏
页码:2275 / 2285
页数:11
相关论文
共 50 条
  • [21] Multiple roles of fucoxanthin and astaxanthin against Alzheimer's disease: Their pharmacological potential and therapeutic insights
    Oliyaei, Najmeh
    Moosavi-Nasab, Marzieh
    Tanideh, Nader
    Iraji, Aida
    BRAIN RESEARCH BULLETIN, 2023, 193 : 11 - 21
  • [22] Astaxanthin, a carotenoid with potential in human health and nutrition
    Hussein, G
    Sankawa, U
    Goto, H
    Matsumoto, K
    Watanabe, H
    JOURNAL OF NATURAL PRODUCTS, 2006, 69 (03): : 443 - 449
  • [23] Astaxanthin, a Potential Preconditioned Neuroprotective Agent to Traumatic Brain Injury
    Heled, Yuval
    Fleischmann, Chen
    Shohami, Esther
    Trembovler, Vika
    Alexandrovich, Alex
    Horowitz, Michal
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2016, 48 (05) : 59 - 59
  • [24] Identification and Determination of Impurities in a New Therapeutic Agent for Fatty Liver Disease
    Shao, Huihui
    Feng, Jing
    Zhang, Hanyilan
    Zhang, Yuanyuan
    Qin, Tong
    Hu, Yuhua
    Zhang, Wenxuan
    Wang, Tiesong
    Wu, Song
    Yang, Qingyun
    JOURNAL OF ANALYTICAL METHODS IN CHEMISTRY, 2023, 2023
  • [25] Liver Growth Factor "LGF" as a Therapeutic Agent for Alzheimer's Disease
    Gonzalo-Gobernado, Rafael
    Perucho, Juan
    Vallejo-Munoz, Manuela
    Jose Casarejos, Maria
    Reimers, Diana
    Jimenez-Escrig, Adriano
    Gomez, Ana
    Ulzurrun de Asanza, Gonzalo M.
    Bazan, Eulalia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (23) : 1 - 21
  • [26] Editorial: Therapeutic potential of cannabinoids: from health to disease
    Salles, Evila Lopes
    Baban, Babak
    Qin, Xu
    Paffaro, Valdemar
    FRONTIERS IN NEUROSCIENCE, 2025, 19
  • [27] Redox regulation in health and disease - Therapeutic potential of berberine
    Siow, Yaw L.
    Sarna, Lindsei
    Karmin, O.
    FOOD RESEARCH INTERNATIONAL, 2011, 44 (08) : 2409 - 2417
  • [28] Therapeutic Potential Of Liver X Receptor (LXR) In Alcoholic Liver Disease (ALD)
    Senqupta, Monideepa
    Chatterjee, Arindam
    Griffett, Kristine
    Flaveny, Colin A.
    Burris, Thomas P.
    HEPATOLOGY, 2016, 64 : 618A - 619A
  • [29] Mechanism insights into the pleiotropic effects of nobiletin as a potential therapeutic agent on non-alcoholic fatty liver disease (NAFLD)
    Ran, Qiqi
    Gan, Qianrong
    Zhu, Ye
    Song, Li
    Shen, Longyu
    Duan, Xinyi
    Zhu, Xinyun
    Huang, Wei
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 173
  • [30] Comprehensive pharmacological and experimental study of Ginsenoside Re as a potential therapeutic agent for non-alcoholic fatty liver disease
    Zhang, Jinshan
    Duan, Mingfei
    Wu, Shaohong
    Jiang, Shan
    Hu, Songhao
    Chen, Wenhui
    Zhang, Junchang
    Quan, Haiyan
    Yang, Wah
    Wang, Cunchuan
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 177